Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
DKN-01 600 mg
DRUG
2 trials
Sponsors
Leap Therapeutics, Inc.
, Johannes Gutenberg University Mainz
Conditions
Hepatocellular Carcinoma
Multiple Myeloma
Phase 1
A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Completed
NCT01711671
Leap Therapeutics, Inc.
Multiple Myeloma
Start: 2013-05-31
End: 2015-07-31
Updated: 2025-08-03
DKN-01 Inhibition in Advanced Liver Cancer
NCT03645980
Johannes Gutenberg University Mainz
Hepatocellular Carcinoma
Start: 2018-10-10
End: 2022-08-31
Target: 70
Updated: 2020-10-22
Related Papers
A phase I dose-escalation study of LRP5/6 antagonist BI 905677 in patients with advanced solid tumors.
2024-11-01
4 citations